Ixchiq
NDC 42515-003
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
Ixchiq is a BLA-approved product labeled by Valneva Scotland Ltd.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 42515-003 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
42515-003
Proprietary Name:
Ixchiq
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Code Navigator:
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
42515
Product Label ID:
FDA Application Number: [6]
BLA125777
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.
Marketing Timeline
Start Marketing Date: [9]
01-15-2024
Listing Expiration Date: [11]
12-31-2025
Exclude Flag: [12]
I
Code Structure Chart
Product Details
What is NDC 42515-003?
The NDC code 42515-003 is assigned by the FDA to the product Ixchiq. This pharmaceutical product is labeled by Valneva Scotland Ltd. and is currently categorized as listed product. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 42515-003-01. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are the uses of this product?
IXCHIQ is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV.This indication is approved under accelerated approval based on anti-CHIKV neutralizing antibody levels [See Clinical Studies (14)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory studies.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CHIKUNGUNYA VIRUS LR2006 OPY1 (ATTENUATED STRAIN) ANTIGEN (UNII: 2RM4VT46R8)
- CHIKUNGUNYA VIRUS LR2006 OPY1 (ATTENUATED STRAIN) ANTIGEN (UNII: 2RM4VT46R8) (Active Moiety)
What is the NDC to RxNorm Crosswalk for this product?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 2673242 - chikungunya virus vaccine live 0.5 ML Injection
- RxCUI: 2673242 - chikungunya virus antigen, live attenuated LR2006 OPY1 strain 2000 UNT Injection
- RxCUI: 2673247 - IXCHIQ vaccine live 0.5 ML Injection
- RxCUI: 2673247 - chikungunya virus antigen, live attenuated LR2006 OPY1 strain 2000 UNT Injection [Ixchiq]
- RxCUI: 2673247 - Ixchiq 2000 UNT Injection
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
